We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Acting Commissioner Ostroff Makes PDUFA Reauthorization Top Priority
Acting Commissioner Ostroff Makes PDUFA Reauthorization Top Priority
With the Prescription Drug User Fee Act set to expire in September 2017, the FDA will kick into full gear on reauthorization negotiations this June, FDA Acting Commissioner Stephen Ostroff said Monday.